Companies in #Skeletal Dysplasia
Found 1 company operating in this sector.
Clinical-stage precision oncology company developing next-generation FGFR inhibitors, including oral dabogratinib for skeletal dysplasia and urologic cancers, using its proprietary SNÅP discovery platform.